Leveraging latent assets to strengthen the COVID-19 response and vaccine roll-out in Africa

Detalles Bibliográficos
Autores principales: Kaseje, Neema, Oruenjo, Kennedy, Kaseje, Dan, Evans, Timothy Grant, Tanner, Marcel, Haines, Andy, Nyikal, James
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8727652/
https://www.ncbi.nlm.nih.gov/pubmed/34045185
http://dx.doi.org/10.1136/bmjgh-2021-006289
_version_ 1784626565507710976
author Kaseje, Neema
Oruenjo, Kennedy
Kaseje, Dan
Evans, Timothy Grant
Tanner, Marcel
Haines, Andy
Nyikal, James
author_facet Kaseje, Neema
Oruenjo, Kennedy
Kaseje, Dan
Evans, Timothy Grant
Tanner, Marcel
Haines, Andy
Nyikal, James
author_sort Kaseje, Neema
collection PubMed
description
format Online
Article
Text
id pubmed-8727652
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-87276522022-01-05 Leveraging latent assets to strengthen the COVID-19 response and vaccine roll-out in Africa Kaseje, Neema Oruenjo, Kennedy Kaseje, Dan Evans, Timothy Grant Tanner, Marcel Haines, Andy Nyikal, James BMJ Glob Health Commentary BMJ Publishing Group 2021-05-27 /pmc/articles/PMC8727652/ /pubmed/34045185 http://dx.doi.org/10.1136/bmjgh-2021-006289 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.
spellingShingle Commentary
Kaseje, Neema
Oruenjo, Kennedy
Kaseje, Dan
Evans, Timothy Grant
Tanner, Marcel
Haines, Andy
Nyikal, James
Leveraging latent assets to strengthen the COVID-19 response and vaccine roll-out in Africa
title Leveraging latent assets to strengthen the COVID-19 response and vaccine roll-out in Africa
title_full Leveraging latent assets to strengthen the COVID-19 response and vaccine roll-out in Africa
title_fullStr Leveraging latent assets to strengthen the COVID-19 response and vaccine roll-out in Africa
title_full_unstemmed Leveraging latent assets to strengthen the COVID-19 response and vaccine roll-out in Africa
title_short Leveraging latent assets to strengthen the COVID-19 response and vaccine roll-out in Africa
title_sort leveraging latent assets to strengthen the covid-19 response and vaccine roll-out in africa
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8727652/
https://www.ncbi.nlm.nih.gov/pubmed/34045185
http://dx.doi.org/10.1136/bmjgh-2021-006289
work_keys_str_mv AT kasejeneema leveraginglatentassetstostrengthenthecovid19responseandvaccinerolloutinafrica
AT oruenjokennedy leveraginglatentassetstostrengthenthecovid19responseandvaccinerolloutinafrica
AT kasejedan leveraginglatentassetstostrengthenthecovid19responseandvaccinerolloutinafrica
AT evanstimothygrant leveraginglatentassetstostrengthenthecovid19responseandvaccinerolloutinafrica
AT tannermarcel leveraginglatentassetstostrengthenthecovid19responseandvaccinerolloutinafrica
AT hainesandy leveraginglatentassetstostrengthenthecovid19responseandvaccinerolloutinafrica
AT nyikaljames leveraginglatentassetstostrengthenthecovid19responseandvaccinerolloutinafrica

Ejemplares similares